Form 4: Beam Therapeutics SVP Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Bethany J. Cavanagh, SVP of Finance and Treasurer at Beam Therapeutics, sold 3,015 shares of common stock on April 1, 2025, to cover tax withholding obligations.
Summary
- On April 1, 2025, Bethany J. Cavanagh, the SVP of Finance and Treasurer at Beam Therapeutics, sold 3,015 shares of common stock.
- The sale was executed at a weighted average price of $18.3516 per share, with individual transactions ranging from $17.76 to $18.38.
- This transaction was conducted to cover tax withholding obligations related to the vesting of restricted stock units.
- The sale was executed automatically under a pre-arranged Rule 10b5-1 trading plan adopted on August 9, 2024.
- Following the transaction, Cavanagh directly owns 44,512 shares of Beam Therapeutics common stock.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a routine transaction related to tax obligations and doesn't reflect a significant change in the executive's outlook on the company.
Industry Context
This is a routine Form 4 filing, reflecting an insider's stock sale to cover tax obligations, a common practice among executives with equity compensation. It doesn't necessarily indicate a change in the executive's confidence in the company.
Stakeholder Impact
- The transaction is unlikely to have a significant impact on stakeholders as it is a routine sale to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| March 31, 2021 | Date of restricted stock unit grant under the Beam Therapeutics Inc. 2019 Equity Incentive Plan. |
| March 31, 2022 | Date of restricted stock unit grant under the Beam Therapeutics Inc. 2019 Equity Incentive Plan. |
| March 31, 2023 | Date of restricted stock unit grant under the Beam Therapeutics Inc. 2019 Equity Incentive Plan. |
| March 31, 2024 | Date of restricted stock unit grant under the Beam Therapeutics Inc. 2019 Equity Incentive Plan. |
| August 9, 2024 | Date the Rule 10b5-1 trading plan was adopted by the Reporting Person. |
| April 1, 2025 | Date of the transaction (stock sale). |
| April 3, 2025 | Date of the Form 4 filing. |
Keywords
Beam Therapeutics, Insider Trading, Form 4, Stock Sale, Tax Withholding, Rule 10b5-1, Equity Incentive Plan, Cavanagh, BEAM
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.